M&A Deal Summary

Warburg Pincus and Illumina Acquire Helix

On August 18, 2015, private equity firm Warburg Pincus and Illumina acquired life science company Helix

Acquisition Highlights
  • This is Warburg Pincus’ 20th and Illumina’s 4th transaction in the Life Science sector.
  • This is Warburg Pincus’ 145th and Illumina’s 8th transaction in the United States.
  • This is Warburg Pincus’ 31st and Illumina’s 5th transaction in California.

M&A Deal Summary
Date 2015-08-18
Target Helix
Sector Life Science
Buyer(s) Warburg Pincus
Illumina
Deal Type Joint Venture

Target

Helix

San Mateo, California, United States
Helix is a population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world’s largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+® assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. Helix is based in San Mateo, California.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1966
PE ASSETS 83.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.

DEAL STATS #
Overall 282 of 482
Sector (Life Science) 20 of 27
Type (Joint Venture) 2 of 4
State (California) 31 of 46
Country (United States) 145 of 237
Year (2015) 17 of 26
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-08-10 Construction Market Data Group

Norcross, Georgia, United States

Construction Market Data Group LLC is a provider of construction information. CMD’s diverse portfolio of innovative products and technologies includes national, regional and local project leads, marketing solutions and market intelligence to provide insight to construction industry professionals throughout the U.S. and Canada.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-01 UCAR

Tianjin, China

UCAR is a chauffeured car service provider in China covering 60 cities through a combination of mobile internet technology, big data, professional drivers and quality rental vehicles. The company is able to guarantee drivers’ background and qualifications as well as vehicle conditions, adopt state-of-the-art technologies to track drivers’ behaviors and promise privacy protection and quick compensation on accidents. UCAR is based in Tianjin, China.

Buy -
Buyer

Illumina

San Diego, California, United States
Category Company
Founded 1998
Sector Life Science
Employees10,590
Revenue 4.5B USD (2023)
DESCRIPTION
Entrance to Illumina's corporate headquarters in San Diego, California.
Entrance to Illumina's corporate headquarters in San Diego, California.

Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. The Company's customers include genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. Illumina was formed in 1998 and is based in San Diego, California.

DEAL STATS #
Overall 9 of 29
Sector (Life Science) 4 of 18
Type (Joint Venture) 1 of 1
State (California) 5 of 11
Country (United States) 8 of 20
Year (2015) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-16 Myraqa

Redwood Shores, California, United States

Myraqa, Inc. is a regulatory and quality consulting firm specializing in IVDs, particularly companion diagnostics.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-01 GenoLogics Life Sciences Software

Victoria, British Columbia, United States

GenoLogics Life Sciences Software, Inc. is a developer of laboratory information management systems (LIMS) for life sciences organizations.

Buy -
Mergr

Product

Company

Legal